首页> 外文OA文献 >B3-03: A randomized multicenter phase III study of cetuximab (Erbitux®) in combination with Taxane/Carboplatin versus Taxane/Carboplatin alone as first-line treatment for patients with advanced/metastatic Non-small cell lung cancer (NSCLC)

【2h】

B3-03: A randomized multicenter phase III study of cetuximab (Erbitux®) in combination with Taxane/Carboplatin versus Taxane/Carboplatin alone as first-line treatment for patients with advanced/metastatic Non-small cell lung cancer (NSCLC)

机译：B3-03：西妥昔单抗（Erbitux®）联合紫杉烷/卡铂与单独使用紫杉烷/卡铂的多中心III期随机研究，作为晚期/转移性非小细胞肺癌（NSCLC）患者的一线治疗

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Lynch Thomas J.; Patel Taral; Dreisbach Luke; McCleod Michael; Heim William J.; Robert Hermann; Eugene Paschold; Virginie Pautret; Weber Martin R.; Woytowitz Donald;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC) [J] . Roger B. Cohen, Corey J. Langer, George Rajan Simon, Cancer Chemotherapy and Pharmacology . 2007,第1期

机译：CP-547,632联合紫杉醇和卡铂或单独使用紫杉醇和卡铂作为晚期非小细胞肺癌（NSCLC）的一线治疗的I期/随机II期，非比较，多中心，开放标签试验
2. Cetuximab and first-line taxane/carboplatin chemotherapy in advanced non-small-cell lung cancer: results of the randomized multicenter phase III trial BMS099. [J] . Lynch TJ, Patel T, Dreisbach Journal of Clinical Oncology . 2010,第6期

机译：西妥昔单抗和一线紫杉烷/卡铂化疗治疗晚期非小细胞肺癌：多中心III期随机试验BMS099的结果。
3. Elderly Subset Analysis of Randomized Phase III Study Comparing Pemetrexed Plus Carboplatin with Docetaxel Plus Carboplatin as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer [J] . José Rodrigues Pereira, Rebecca Cheng, Mauro Orlando, Drugs in R&D . 2013,第4期

机译：培美曲塞加卡铂与多西他赛加卡铂作为一线治疗局部晚期或转移性非小细胞肺癌患者的随机III期研究的老年人亚组分析
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. Taxane conjugate nanoparticles for improved non-small cell lung cancer treatment in a novel orthotopic mouse model. [D] . Peng, Lei. 2014

机译：紫杉烷共轭纳米颗粒在新型原位小鼠模型中用于改善非小细胞肺癌的治疗。
6. Elderly Subset Analysis of Randomized Phase III Study Comparing Pemetrexed Plus Carboplatin with Docetaxel Plus Carboplatin as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer [O] . José Rodrigues Pereira, Rebecca Cheng, Mauro Orlando, -1

机译：培美曲塞加卡铂与多西他赛加卡铂作为一线治疗局部晚期或转移性非小细胞肺癌患者的随机III期研究的老年人亚组分析
7. Elderly Subset Analysis of Randomized Phase III Study Comparing Pemetrexed Plus Carboplatin with Docetaxel Plus Carboplatin as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer [O] . 2013

机译：培美曲塞加卡铂与多西他赛加卡铂作为一线治疗局部晚期或转移性非小细胞肺癌患者的随机III期研究的老年人亚组分析

B3-03: A randomized multicenter phase III study of cetuximab (Erbitux®) in combination with Taxane/Carboplatin versus Taxane/Carboplatin alone as first-line treatment for patients with advanced/metastatic Non-small cell lung cancer (NSCLC)

著录项

引文网络

相似文献

相关主题

期刊订阅